ITS BIO

AffinityImmuno Products

ELISA kits, research antibodies, biosimilars and isotype controls from AffinityImmuno.

EL-141-PEG-hIGM

EL-141-PEG-hIGM image 1

AffinityImmuno · ELISA Kit

Anti PEG antibody ELISA (human IgM specific)

Cat.No

EL-141-PEG-hIGM

1X96 wells

Antigen
Anti-PEG human IgM antibodies
Reactivity
human
Detection range
62.5 ng/mL -1000 ng/mL
Detection minimum
62.5 ng/mL
Sample type
Serum Plasma
Assay time
2.5 hours

Product Overview

This immunogenicity assay measures the presence of human IgM in serum or plasma that bind to immobilized PEG using the indirect ELISA technique.

Introduction

Polyethylene glycol (PEG) chains are often used to modify therapeutic biologic agents in order to prolong the circulating half-life of the modified protein by slowing proteolytic degradation. It has been reported that repeat injections of PEGylated proteins can induce anti-PEG antibodies. Anti-PEG antibodies can result in rapid clearance and decreased drug efficacy (accelerated blood clearance, or ABC, phenomenon).

Principle of the Assay

This immunogenicity assay measures the presence of human IgM in serum or plasma that bind to immobilized PEG using the indirect ELISA technique. The supplied 96 well microplate is pre-coated with PEG. After washing, quality control and test samples are pipetted into the appropriate wells. Anti-PEG antibodies bind the immobilized PEG. After washing, detection antibody (anti human IgM Peroxidase) is added. Any unbound antibody enzyme reagent is removed with a final wash and a substrate solution is added to the wells for color development. Color development is proportional to the amount of anti-PEG IgM.

Related assays

Also available in other species/isotype specificities: human IgG, mouse IgG, and mouse IgM.

Related reading

For context on anti-PEG IgM prevalence and clinical significance in human samples, see our 2026 PEG immunogenicity review.

Target background

Polyethylene glycol (PEG) chains are often used to modify therapeutic biologic agents in order to prolong the circulating half-life of the modified protein. It has been reported that repeat injections of PEGylated proteins can induce anti-PEG antibodies.

Need assistance?
Contact our experts for support and fast quotations.
(주)이츠바이오
07532 서울특별시 강서구 양천로 551-17 한화비즈메트로 1차 812호
T : 02-3462-8658  F : 02-3462-8659
E-mail : info@itsbio.co.kr
ITSBio, Inc.
812, Hanwha Bizmetro A-dong, 551-17 YangcheonRo, Gangseo-Gu, Seoul, 07532, Korea, Republic of
T : +82-2-3462-8658  F : +82-2-3462-8659
E-mail : info@itsbio.co.kr
Privacy Policy|Terms|© 2026 ITS BIO. All rights reserved.
Online Message
Send to info@itsbio.co.kr